ライフサイエンスコーパス: severe depression

1 score, 0 to 60; higher scores indicate more severe depression).

2 end toward higher risks for exposure to more severe depression.

3 is one of the most effective treatments for severe depression.

4 ECT is the most effective treatment for severe depression.

5 is a robust and rapidly acting treatment for severe depression.

6 ere gastroesophageal reflex, and moderate to severe depression.

7 it was 60.3; 27% of patients had moderate to severe depression.

8 ajor depression is overstated and limited to severe depression.

9 tidepressants show little benefit except for severe depression.

10 ssociations may reflect drug effects or more severe depression.

11 herapy (ECT) is the most potent treatment in severe depression.

12 ative to pill placebo for patients with less severe depression.

13 ia; anxious or melancholic features; or more severe depression.

14 selected to represent those with moderate to severe depression.

15 nt was predicted by integrated care and more severe depression.

16 low-up, and drug treatment for patients with severe depression.

17 dicts early recovery among persons with less severe depression.

18 people with self-defined anxiety attacks and severe depression.

19 h other neuropsychiatric symptoms, including severe depression.

20 ld depression, and gender is associated with severe depression.

21 rized as no depression, mild depression, and severe depression.

22 iciency is associated with a twofold risk of severe depression.

23 and deflate heritability estimates for less severe depression.

24 tion (2.8 [0.17] vs 2.2 [0.13]; P =.008) and severe depression (1.9 [0.15] vs 0.9 [0.09]; P<.001), re

25 ere more likely than men to have moderate to severe depression (18.0% vs 9.0%; 95% CI for difference,

26 73+/-13 years; 58% men), 15% had moderate to severe depression, 26% mild, and 59% none to minimal dep

27 tacks" in the past 12 months; 7.2% reported "severe depression." A total of 56.7% of those with anxie

28 and psychological problems (eg, moderate to severe depression according to the Patient Health Questi

29 of those seen by a conventional provider for severe depression also used complementary and alternativ

30 ioral and volitional changes which accompany severe depression and its treatment.

31 this study eventually recovered, those with severe depression and self-perceived parent-child confli

32 esting that this may be a surrogate for more severe depression and that severity of depression is ass

33 iated with increased risk for schizophrenia, severe depression, and other nonaffective psychoses, but

34 ciated with increased risk of schizophrenia, severe depression, and other nonaffective psychoses.

35 al problems including cardiovascular injury, severe depression, and psychosis.

36 with a long illness duration and moderate to severe depression appear to benefit from antidepressants

37 ction, showed that patients with moderate to severe depression at baseline (adjusted hazard ratio [HR

38 Patients had chronic moderate to severe depression at baseline (the mean MADRS score was

39 However, patients with severe depression (baseline Hamilton depression scale sc

40 oms for patients with persistent moderate to severe depression, but functional outcomes and economic

41 ropean countries to treat mild to moderately severe depression, but the mechanism of antidepressant a

42 n (CES-D 16-26) and 97 (12%) for moderate to severe depression (CES-D > or =27).

43 Students with moderate to severe depression, compared with no to minimal depressio

44 antidepressant medications treat moderate to severe depression effectively, but there is less data on

45 re 9 (PHQ-9) indicating moderately severe to severe depression from ten primary health centres in Goa

46 he depressed subjects, especially those with severe depression, had a significantly higher serum meth

47 Preoperatively, severe depression (HADS score >/= 11) was seen in 20% of

48 Less severe depression, having received adequate antidepressa

49 Elderly individuals with severe depression, history of suicide attempts with seri

50 Health Questionnaire-9 detected moderate to severe depression in 17% of the patients with pHPT and 7

51 eceptor signaling respond to dopamine with a severe depression in action potential firing rate, while

52 base supporting the efficacy of ECT to treat severe depression in elderly patients.

53 reduce depressive symptoms and prevent more severe depression in older people.

54 ellors to patients with moderately severe to severe depression in primary health-care settings.

55 e was for patients with moderately severe to severe depression in routine primary care in Goa, India.

56 e was for patients with moderately severe to severe depression in routine primary care in Goa, India.

57 ncer, one of pancreatitis/sepsis, and one of severe depression leading to noncompliance.

58 ls pretreated with antidepressants have less severe depression-like symptoms after the administration

59 vior was closely associated with moderate to severe depression, male gender, and greater impairment i

60 ost commonly reported events were psychosis, severe depression, mania or agitation, hallucinations, s

61 tance abuse, and less history at baseline of severe depression, manic symptoms, suicidality, subsyndr

62 ly recruit patients with at least moderately severe depression may be more informative and efficient

63 rformance was observed between more and less severe depression, men and women, and primary versus spe

64 Severe depression necessitated the discontinuation of in

65 ormance (odds ratio=1.60, 95% CI=1.02-2.49), severe depression (odds ratio=2.62, 95% CI=1.34-5.10), a

66 The severe depression of cardiac function responded promptly

67 alpha reactivation concomitantly resulted in severe depression of cardiac power and efficiency in the

68 and elevated SA, which appear to result from severe depression of catalase levels, may be responsible

69 single HisRS gene in T. brucei is shown by a severe depression of parasite growth rate that results f

70 -65 years screened with moderately severe to severe depression on the Patient Health Questionnaire 9

71 ental disorders, identified as self-reported severe depression or other psychological distress, were

72 However, few studies included women with severe depression or suicidal ideation.

73 ported by volunteers without severe anxiety, severe depression, or cognitive problems.

74 ICD-positive patients had more severe depression, poorer sleep quality and reduced qual

75 s who were assigned to intervention had less severe depression (range, 0 to 4 on a checklist of 20 de

76 with anxiety attacks and 53.6% of those with severe depression reported using complementary and alter

77 of premorbid IQ score and risk of developing severe depression requiring hospital admission.

78 vovirus infection, aspiration pneumonia, and severe depression, respectively.

79 6 and > or =27 represented mild and moderate/severe depression, respectively.

80 s, and 29.1% of the subjects had moderate to severe depression (score > or =21).

81 Pooling of studies examining severe depression showed a 5% decrease in risk of severe

82 phic sleep profile) and more severe and less severe depression subgroups (on the basis of pretreatmen

83 alence of symptoms of social dysfunction and severe depression suggest the need for implementation of

84 I 1.4-4.0]; p=0.001) and mild or moderate to severe depression that persisted from baseline to 6 mont

85 For patients with very severe depression, the benefit of medications over place

86 Severe depression, trait anxiety, and poor visuospatial

87 In adolescents with moderate to severe depression, treatment with fluoxetine alone or in

88 y 54.9% of all participants with moderate to severe depression used antidepressants, suggesting under

89 with anxiety attacks and 19.3% of those with severe depression visited a complementary or alternative

90 Prevalence of moderate to severe depression was 14.3% (95% confidence interval [CI

91 After adjustment, moderate to severe depression was associated with nearly a 2-fold in

92 Moderate/severe depression was associated with time to first shoc

93 .1% of the participants, whereas moderate to severe depression was found in 12.7%.

94 Subjects with marked or severe depression were more likely to respond to the scr

95 pressive symptoms, syndromal depression, and severe depression-were assessed over the 5 years before

96 ngside CBT, for adolescents with moderate to severe depression who are attending routine specialist C

97 e depression showed a 5% decrease in risk of severe depression with increasing (2-year increment) age

98 Current guidelines recommend treating severe depression with pharmacotherapy.